322 related articles for article (PubMed ID: 18350595)
1. Natural history of hepatitis-related hepatocellular carcinoma.
But DY; Lai CL; Yuen MF
World J Gastroenterol; 2008 Mar; 14(11):1652-6. PubMed ID: 18350595
[TBL] [Abstract][Full Text] [Related]
2. Comparison of surgical outcomes for small hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a Chinese experience.
Li Q; Li H; Qin Y; Wang PP; Hao X
J Gastroenterol Hepatol; 2007 Nov; 22(11):1936-41. PubMed ID: 17914973
[TBL] [Abstract][Full Text] [Related]
3. Influence of hepatitis viruses on clinicopathological profiles and long-term outcome in patients undergoing surgery for hepatocellular carcinoma.
Tanase AM; Dumitrascu T; Dima S; Grigorie R; Marchio A; Pineau P; Popescu I
Hepatobiliary Pancreat Dis Int; 2014 Apr; 13(2):162-72. PubMed ID: 24686543
[TBL] [Abstract][Full Text] [Related]
4. Independent Predictors of Mortality and Resource Utilization in Viral Hepatitis Related Hepatocellular Carcinoma.
Golabi P; Jeffers T; Younoszai Z; Otgonsuren M; Sayiner M; Mishra A; Venkatesan C; Younossi ZM
Ann Hepatol; 2017; 16(4):555-564. PubMed ID: 28611258
[TBL] [Abstract][Full Text] [Related]
5. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
[TBL] [Abstract][Full Text] [Related]
6. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B- and C-related hepatocellular carcinomas yield different clinical features and prognosis.
Chen CH; Huang GT; Yang PM; Chen PJ; Lai MY; Chen DS; Wang JD; Sheu JC
Eur J Cancer; 2006 Oct; 42(15):2524-9. PubMed ID: 16920352
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohort.
Sinn DH; Gwak GY; Cho J; Paik SW; Yoo BC
PLoS One; 2014; 9(11):e112184. PubMed ID: 25372403
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, risk factors, and natural history of hepatocellular carcinoma.
Montalto G; Cervello M; Giannitrapani L; Dantona F; Terranova A; Castagnetta LA
Ann N Y Acad Sci; 2002 Jun; 963():13-20. PubMed ID: 12095924
[TBL] [Abstract][Full Text] [Related]
10. Patterns of hepatocellular carcinoma development in hepatitis B virus and hepatitis C virus related cirrhosis.
Benvegnù L; Alberti A
Antiviral Res; 2001 Nov; 52(2):199-207. PubMed ID: 11672830
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and prevention of hepatocellular carcinoma in HCV infection.
Benvegnù L; Alberti A
Dig Dis Sci; 1996 Dec; 41(12 Suppl):49S-55S. PubMed ID: 9011476
[TBL] [Abstract][Full Text] [Related]
12. Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resection.
Huo TI; Wu JC; Lui WY; Lee PC; Huang YH; Chau GY; Tsay SH; Chang FY; Lee SD
Eur J Gastroenterol Hepatol; 2003 Nov; 15(11):1203-8. PubMed ID: 14560154
[TBL] [Abstract][Full Text] [Related]
13. Impact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a north american center.
Lee JJ; Kim PT; Fischer S; Fung S; Gallinger S; McGilvray I; Moulton CA; Wei AC; Greig PD; Cleary SP
Ann Surg Oncol; 2014 Aug; 21(8):2708-16. PubMed ID: 24806113
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology and prevention of hepatocellular carcinoma.
Monto A; Wright TL
Semin Oncol; 2001 Oct; 28(5):441-9. PubMed ID: 11685737
[TBL] [Abstract][Full Text] [Related]
15. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.
Benvegnù L; Fattovich G; Noventa F; Tremolada F; Chemello L; Cecchetto A; Alberti A
Cancer; 1994 Nov; 74(9):2442-8. PubMed ID: 7922998
[TBL] [Abstract][Full Text] [Related]
16. Hospital- and community-based screenings for hepatocellular carcinoma in Taiwan.
Kee KM; Lu SN
Oncology; 2011; 81 Suppl 1():36-40. PubMed ID: 22212934
[TBL] [Abstract][Full Text] [Related]
17. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
18. Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?
Lok AS
J Gastroenterol Hepatol; 2011 Feb; 26(2):221-7. PubMed ID: 21070361
[TBL] [Abstract][Full Text] [Related]
19. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
Shiratori Y; Shiina S; Zhang PY; Ohno E; Okudaira T; Payawal DA; Ono-Nita SK; Imamura M; Kato N; Omata M
Cancer; 1997 Dec; 80(11):2060-7. PubMed ID: 9392327
[TBL] [Abstract][Full Text] [Related]
20. Comparison of prognosis by viral etiology in patients with hepatocellular carcinoma after radiofrequency ablation.
Chen PH; Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Chao Y; Lin HC; Wu JC
Ann Hepatol; 2013; 12(2):263-73. PubMed ID: 23396738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]